HUT68249A - 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor and pharmaceutical composition containing it and process for producing thereof - Google Patents
2,6-methano-2h-quinolizin derivative as 5-ht3-receptor and pharmaceutical composition containing it and process for producing thereofInfo
- Publication number
- HUT68249A HUT68249A HU9402436A HU9402436A HUT68249A HU T68249 A HUT68249 A HU T68249A HU 9402436 A HU9402436 A HU 9402436A HU 9402436 A HU9402436 A HU 9402436A HU T68249 A HUT68249 A HU T68249A
- Authority
- HU
- Hungary
- Prior art keywords
- quinolizin
- methano
- receptor
- derivative
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP92400474 | 1992-02-24 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU9402436D0 HU9402436D0 (en) | 1994-10-28 |
| HUT68249A true HUT68249A (en) | 1995-06-28 |
| HU216831B HU216831B (hu) | 1999-09-28 |
Family
ID=8211614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9402436A HU216831B (hu) | 1992-02-24 | 1993-02-03 | Eljárás 5-HT3-receptor antagonista 2,6-metano-2H-kinolizin-származék és az ezt tartalmazó gyógyszerkészítmény előállítására |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0628043A1 (hu) |
| JP (1) | JPH07504192A (hu) |
| KR (1) | KR100287933B1 (hu) |
| AU (1) | AU675060B2 (hu) |
| CA (1) | CA2130563C (hu) |
| FI (1) | FI105917B (hu) |
| HU (1) | HU216831B (hu) |
| IL (1) | IL104821A (hu) |
| MX (1) | MX9300948A (hu) |
| NO (1) | NO943101D0 (hu) |
| NZ (1) | NZ249346A (hu) |
| TW (1) | TW226374B (hu) |
| WO (1) | WO1993017019A1 (hu) |
| ZA (1) | ZA931146B (hu) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000048597A1 (en) | 1999-02-18 | 2000-08-24 | Novartis Ag | Systemic use of 5-ht3 receptor antagonists against rheumatic inflammatory processes |
| US8518962B2 (en) | 2005-03-07 | 2013-08-27 | The University Of Chicago | Use of opioid antagonists |
| US8524731B2 (en) | 2005-03-07 | 2013-09-03 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| US9662325B2 (en) | 2005-03-07 | 2017-05-30 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| CN101171010B (zh) | 2005-03-07 | 2014-09-17 | 芝加哥大学 | 阿片样物质拮抗剂用于减少内皮细胞增殖和迁移的用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2080727T3 (es) * | 1988-02-23 | 1996-02-16 | Merrell Pharma Inc | Uso de quinolizina y derivados de quinolizinona en la fabricacion de medicamentos. |
| EP0517984A1 (en) * | 1991-06-11 | 1992-12-16 | Merrell Dow Pharmaceuticals Inc. | Derivatives of amide analogs of certain methano bridged quinolizines |
-
1993
- 1993-02-03 KR KR1019940702945A patent/KR100287933B1/ko not_active IP Right Cessation
- 1993-02-03 WO PCT/US1993/000880 patent/WO1993017019A1/en active IP Right Grant
- 1993-02-03 NZ NZ249346A patent/NZ249346A/en not_active IP Right Cessation
- 1993-02-03 CA CA002130563A patent/CA2130563C/en not_active Expired - Lifetime
- 1993-02-03 HU HU9402436A patent/HU216831B/hu unknown
- 1993-02-03 EP EP93904797A patent/EP0628043A1/en not_active Withdrawn
- 1993-02-03 JP JP5514868A patent/JPH07504192A/ja active Pending
- 1993-02-03 AU AU36034/93A patent/AU675060B2/en not_active Expired
- 1993-02-18 ZA ZA931146A patent/ZA931146B/xx unknown
- 1993-02-19 TW TW082101189A patent/TW226374B/zh not_active IP Right Cessation
- 1993-02-22 IL IL10482193A patent/IL104821A/xx not_active IP Right Cessation
- 1993-02-22 MX MX9300948A patent/MX9300948A/es unknown
-
1994
- 1994-08-23 FI FI943872A patent/FI105917B/fi not_active IP Right Cessation
- 1994-08-23 NO NO943101A patent/NO943101D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA931146B (en) | 1993-09-14 |
| HU216831B (hu) | 1999-09-28 |
| IL104821A (en) | 1997-01-10 |
| NO943101L (no) | 1994-08-23 |
| KR950700297A (ko) | 1995-01-16 |
| CA2130563A1 (en) | 1993-09-02 |
| EP0628043A1 (en) | 1994-12-14 |
| FI943872A (fi) | 1994-08-23 |
| FI943872A0 (fi) | 1994-08-23 |
| IL104821A0 (en) | 1993-06-10 |
| WO1993017019A1 (en) | 1993-09-02 |
| MX9300948A (es) | 1993-08-01 |
| HU9402436D0 (en) | 1994-10-28 |
| NZ249346A (en) | 1995-10-26 |
| AU675060B2 (en) | 1997-01-23 |
| KR100287933B1 (ko) | 2001-05-02 |
| FI105917B (fi) | 2000-10-31 |
| NO943101D0 (no) | 1994-08-23 |
| AU3603493A (en) | 1993-09-13 |
| JPH07504192A (ja) | 1995-05-11 |
| TW226374B (hu) | 1994-07-11 |
| CA2130563C (en) | 1997-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9400413D0 (en) | Imidazoly-alcenoic acids, pharmaceutical compositions containing them, and process for producing them | |
| HUP9900055A3 (en) | 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridin -derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUT67375A (en) | 1,5-benzodiazepine derivatives, pharmaceutical compositions containing them and process for their producing | |
| HU9303252D0 (en) | New thiopyrano-pyrrole derivatives, pharmaceutical compositions containing them and process for producing them | |
| HUT53362A (en) | Process for producing substituted 1,3-oxathiolans and pharmaceutical compositions comprising same | |
| HUT73850A (en) | 4-aza-androstenone derivative, pharmaceutical composition containing it, process for their production and intermediates | |
| HUT64734A (en) | Anthraquinone-derivativdes, process for preparing them and pharmaceutical compositions containing them | |
| HUT62559A (en) | Process for producing 1 alpha-hydroxy-d4-vitamins and pharmaceutical compositions comprising same | |
| HUT54139A (en) | Process for producing n-heteroaryl-4-quinolineamine derivatives and pharmaceutical compositions comprising such compounds | |
| HUP9601034A3 (en) | Aryl-alkyl-pyridazinone compounds, process for producing them, and pharmaceutical compositions containing them | |
| HU9402187D0 (en) | Heterocyclic compounds, process for producing them and pharmaceutical compositions containing them | |
| HU9402292D0 (en) | New baccatine-iii and 10-deacetyl-baccatine-iii derivatives, process for producing them and pharmaceutical compositions containing them as active component | |
| HUT74615A (en) | 2,3-cyclic-condensed-1,4-dihydro-pyridine derivatives, process for producing them and pharmaceutical compositions containing the same | |
| HU9400934D0 (en) | Thiadiazinone derivatives, pharmaceutical compositions containing them and process for producing them | |
| HUT61548A (en) | Process for producing indolonaphthyridine derivatives and pharmaceutical compositions comprising such compounds | |
| HU9303376D0 (en) | Process for producing alpha, omega-diaryl-alkane derivatives and pharmaceutical compositions containing them | |
| HUT65768A (en) | 17-beta-substituted 4-aza-androstane-derivatives and pharmaceutical compositions containing them and process for the production thereof | |
| HU904661D0 (en) | 14,17-alpha-etheno- and -ethano-esthatrienes and process for producing these compounds as well as pharmaceutical preparatives containing them | |
| HUT68249A (en) | 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor and pharmaceutical composition containing it and process for producing thereof | |
| HU9303322D0 (en) | Pyrrole derivatives, process for producing them and pharmaceutical compositions containing them | |
| HU9400909D0 (en) | 1,2,5,6-terrahydro-pyridine derivative pharmaceutical compositions containing them and process for producing them | |
| HUT71349A (en) | Heteroaryl-piperidine derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUT63162A (en) | Process for producing 1,4-benzodiazepine derivatives and pharmaceutical compositions comprising same | |
| HUP0004177A3 (en) | 4,5-diaryloxazole derivatives, pharmaceutical compositions containing them and process for producing them | |
| HUT49870A (en) | Process for producing new 1,2-dithiolo-3-thion-s-oxide derivatives and pharmaceutical compositions comprising these compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB9A | Succession in title |
Owner name: AVENTISUB II INC., US Free format text: FORMER OWNER(S): AVENTIS INC., US; MERREL DOW PHARMACEUTICALS INC., US |